Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin.


Ciprofloxacin, a quinolone with good intracellular penetration may possibly be used for treatment of melioidosis caused by Burkholderia pseudomallei, but problems with resistance may be encountered. Amino acid substitutions in gyrA/gyrB have given rise to fluoroquinolone resistance in various microorganisms. Using published primers for gyrA and gyrB, PCR… (More)

1 Figure or Table


  • Presentations referencing similar topics